Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Plasma glial fibrillary acidic protein as a mediator of amyloid‐associated cognitive decline over 4‐year follow‐up in pre‐dementia stages2026
2. 2Exploring the links between amyloid, astrocytic activation, and tau biomarkers in a memory clinic cohort across the Alzheimer’s disease continuum2026
3. 3Association Between Plasma GFAP and Medial Temporal Atrophy and Cognition in Amyloid-Negative Cerebrovascular Disease2026
4. 4Moderating effects of plasma glial fibrillary acidic protein along the Alzheimer's disease continuum2025 · 3 citations
5. 5Prognostic value of plasma glial fibrillary acidic protein in cognitively unimpaired older adults: Results from the A4 study2025